Abstract:G A A b st ra ct s these findings. The present study seeks to identify biologic differences in methylation among these three racial/ethnic groups. Methods: We performed an array-based study of aberrantly methylated loci in CRCs and neighboring normal tissue using HumanMethylation450 arrays (Illumina). Paired FFPE CRC samples (n=42) and neighboring normal tissue were obtained from the case records of the pathology department at the University of Miami Hospital and Sylvester Comprehensive Cancer Center (Miami, FL). Samples were segregated into racial/ ethnic categories of black, Hispanic, and NHW and matched for age and stage. DNA was extracted from 10 micron thick colon tissue resection samples, with target enrichment, sequencing, and automated analysis performed using manufacturer protocols for the HumanMethylation450 array. Methylome-wide tumor vs. normal differential methylation was performed on each sample pair. Significantly methylated loci (FDRpu003c0.05) in ≥90% of samples in each ethnic group were prioritized, and overlap was sought between ethnic groups. Pathway and gene ontology analyses were conducted assuming a hypergeometric model with the MetaCore software. Results: 13 BNH, 18 Hispanic, and 11 NHW matched pairs of normal colon and CRC were included. 10 differentially methylated regions (DMRs) were significant both within and across all ethnic groups. All DMRs were hypermethylated, previously shown to be hypermethylated in cell lines, and several (e.g., MDFI, RYR2, OPLAH) were identified as top hits from published independent genome-wide methylation analyses. 73, 329, and 2379 DMRs were unique to Black, Hispanic, and NHW groups, respectively. The CpG sites that were differentially methylated (both hypoand hyper-methylation) were localized to intragenic and intergenic regions. Pathway analyses revealed unique signatures of methylation targets between ethnic groups. In contrast to Black and Hispanic datasets, the colorectal cancer (general schema) pathway was significant (FDRpu003c0.05) only in NHW. Conclusions: These results confirm common CRC methylation signals independent of racial/ ethnic labels and also reveal potential racialand ethnic-specific CRC methylation signatures. Clarification of these findings may contribute to the understanding of the phenotypic differences observed in patients with CRC among these groups.

The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

Increased methylation variation in epigenetic domains across cancer types

Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts

Cpg Island Methylation In Aberrant Crypt Foci And Cancers From The Same Patients

The relationship between hypomethylation and CpG island methylation in colorectal neoplasia

Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age

DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns

Identification of Transcription Factor/Gene Axis in Colon Cancer Using a Methylome Approach

Promoter Hypermethylation Of A Novel Tumor Suppressor Gene Chondrolectin In Colorectal Cancer

Identifying CpG Sites with Different Differential Methylation Frequencies in Colorectal Cancer Tissues Based on Individualized Differential Methylation Analysis

Identification of Regulatory Role of DNA Methylation in Colon Cancer Gene Expression Via Systematic Bioinformatics Analysis

Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon

Dynamic DNA methylation across diverse human cell lines and tissues

Genome-wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters

Changes in correlation between promoter methylation and gene expression in cancer

Integrated Analyses of Multi-Omics Reveal Global Patterns of Methylation and Hydroxymethylation and Screen the Tumor Suppressive Roles of HADHB in Colorectal Cancer

Genome-wide screening and functional validation of methylation barriers near promoters

Genome-wide Analysis of Aberrant DNA Methylation for Identification of Potential Biomarkers in Colorectal Cancer Patients.

Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers

High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer.

Gene promoter and exon DNA methylation changes in colon cancer development – mRNA expression and tumor mutation alterations